DocDollars

Aveo Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000971865

Total reported 2019–2025
$32.1M
#225 of 2,960 reporting companies — 0% of all reported industry payments
$1.98M in general payments across 21,452 records, plus $30.1M in research funding across 6,544 records.

How it breaks down

General payments $1,975,243
Research funding $30,101,679

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Aveo Pharmaceuticals, Inc. reported $32.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #225 of 2,960 reporting companies. 94% of that was research funding and 6% general payments such as consulting, speaking, food and travel. 21,452 general payment records and 6,544 research records were filed.

Common questions about Aveo Pharmaceuticals, Inc.

How much has Aveo Pharmaceuticals, Inc. paid US doctors?

Aveo Pharmaceuticals, Inc. reported $32,076,921 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,975,243 in general payments, $30,101,679 in research funding.

How does Aveo Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #225 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Aveo Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.